Corynebacterium coyleae sp. nov., isolated from human clinical specimens

International Journal of Systematic Bacteriology
G FunkeMatthew D Collins

Abstract

Over a 5-year period, six isolates of a previously unknown nonlipophilic coryneform bacterium were isolated from human clinical specimens. The most characteristic phenotypic reactions of these isolates included slow fermentative acid production from glucose but no acid production from maltose and sucrose and a strongly positive CAMP reaction. Chemotaxonomic investigations revealed that meso-diaminopimelic acid and mycolic acids were present, that palmitic, oleic, and stearic acids were the predominant cellular fatty acids, and that the G + C content was 62 to 64 mol%, characteristics which are consistent with assignment to the genus Corynebacterium. Phenotypically, the unknown coryneform bacterium could be readily differentiated from all other Corynebacterium species. A 16S rRNA gene sequence analysis and quantitative DNA-DNA hybridization experiments demonstrated unambiguously that the unknown coryneform bacterium is a member of the genus Corynebacterium and is genotypically distinct from all other members of this genus. Based on phenotypic and genotypic findings, a new species, Corynebacterium coyleae sp.nov., is proposed. The type strain of C coylease is strain DSM 44184 (= CCUG 35014).

Citations

Nov 10, 2007·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M I Fernández-NatalF Soriano
Sep 10, 2014·Standards in Genomic Sciences·Sophie EdouardDidier Raoult
Aug 13, 2009·International Journal of Systematic and Evolutionary Microbiology·M Aravena-RomanA F Yassin
Nov 17, 2004·International Journal of Systematic and Evolutionary Microbiology·J F Fernández-GarayzábalM D Collins
Jun 7, 2007·International Journal of Systematic and Evolutionary Microbiology·A F Yassin
Apr 29, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Beata Sokol-LeszczynskaGrazyna Mlynarczyk
Nov 15, 2018·JMM Case Reports·Claudia M BarberisCarlos Vay
Jul 3, 1998·Journal of Clinical Microbiology·A von GraevenitzG Funke
Aug 1, 1997·Journal of Clinical Microbiology·G FunkeM D Collins
Dec 17, 1997·Journal of Clinical Microbiology·G FunkeP Riegel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology
A Von Graevenitz, G Funke
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J WagnerH Hahn
© 2022 Meta ULC. All rights reserved